Lundbeck increases research and development budget

Researchers and developers at Lundbeck will have more money to play with from 2020 onwards, as the company accelerates development on a number of drug candidates in order to ensure long-term growth.

Photo: Martin Lehmann

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles